Clinical Trial Update: Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial [Phase 3]

View source ↗

Summary

Phase 3 PRECISIONS trial in idiopathic pulmonary fibrosis has completed, evaluating genotype-guided selection of N-acetylcysteine therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Fernando J Martinez | Conditions: Idiopathic Pulmonary Fibrosis | Phase 3 | Status: COMPLETED